Related Experiment Video
Updated: Jan 2, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
IL-24 Inhibits Lung Cancer Growth by Suppressing GLI1 and Inducing DNA Damage
Janani Panneerselvam1,2, Akhil Srivastava1,2, Meghna Mehta2,3
1Department of Pathology, The University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA.
Abstract:
Aberrant expression of GLI1 is responsible for aggressive tumor behavior and survival due to its effects on the DNA damage response (DDR). We investigated whether interleukin (IL)-24, a tumor suppressor, inhibits GLI1 and the associated DDR pathway in human NSCLCs. IL-24 treatment reduces mRNA and protein expression of GLI1 in lung tumor cells, but not in normal cells. GLI1 reporter assay and mRNA studies demonstrated that IL-24 regulates GLI1 at the post-transcriptional level by favoring mRNA degradation. Associated with GLI1 inhibition was marked suppression of the ATM-mediated DDR pathway resulting in increased DNA damage, as evidenced by γ-H2AX foci and Comet assay. Furthermore, attenuation of GLI1-associated DDR by IL-24 increased caspase-3 and PARP activity, resulting in cancer cell apoptosis. GLI1 inhibition and overexpression confirmed that IL-24-mediated anti-tumor effects involved the GLI-dependent pathway. Finally, we observed that IL-24-mediated alteration in GLI1 is independent of the canonical hedgehog-signaling pathway. Our study provides evidence that IL-24 treatment induces DNA damage, and reduces GLI1 expression and offers an opportunity for testing IL-24-based therapy for inhibiting GLI1 in lung cancer.
Insights
Interleukin-24 (IL-24) suppresses GLI1 expression and the DNA damage response (DDR) pathway in non-small cell lung cancer (NSCLC). This inhibition promotes cancer cell apoptosis, offering a potential therapeutic strategy for lung cancer.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Aberrant GLI1 expression drives aggressive tumor behavior and survival by influencing the DNA damage response (DDR).
- Interleukin-24 (IL-24) is a tumor suppressor with potential roles in modulating cancer pathways.
Purpose of the Study:
- To investigate if IL-24 inhibits GLI1 and its associated DDR pathway in human non-small cell lung cancers (NSCLCs).
Main Methods:
- Assessed GLI1 mRNA and protein levels following IL-24 treatment in NSCLC cells.
- Utilized GLI1 reporter assays and mRNA studies to determine regulation mechanisms.
- Evaluated DDR pathway activation via γ-H2AX foci and Comet assays.
- Measured apoptosis markers (caspase-3, PARP activity) and employed GLI1 inhibition/overexpression studies.
Main Results:
- IL-24 treatment significantly reduced GLI1 mRNA and protein expression in lung tumor cells, but not normal cells.
- IL-24 mediated post-transcriptional regulation of GLI1, promoting mRNA degradation.
- Suppression of GLI1 correlated with inhibited ATM-mediated DDR, increased DNA damage, and enhanced cancer cell apoptosis.
- IL-24's anti-tumor effects were confirmed to be GLI-dependent and independent of the canonical hedgehog-signaling pathway.
Conclusions:
- IL-24 treatment effectively reduces GLI1 expression and inhibits the DDR pathway in NSCLC.
- IL-24 induces DNA damage and apoptosis in cancer cells, mediated by GLI1 suppression.
- IL-24 represents a promising therapeutic agent for targeting GLI1 in lung cancer treatment.
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Inhibition of Cdk Activity